Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin and Tretinoin Gel for Mild to Moderate Acne
NCT00838812Phase 3Completed
- Sponsor
- Theraskin
- Start
- Mar 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of clindamycin and tretinoin in acne vulgaris, sponsored by Theraskin. Primary endpoints: Evaluation of the efficacy, through number of lesions at 3 months and Evaluation of the tolerability of the product at 3 months. Started Mar 2009; status: completed.
02
Drugs
clindamycintretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00838812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00838812.